Evofem Biosciences announces first patient enrolled in phase 2b/3 STI trial of Amphora ® and expects phase 3 contraceptive clinical trial data first quarter 2019
January 2018
Click for full info +Full Info:
Resource Type:
Citation:
(2018, January 23). Evofem.
Health Risks(s):
- Chlamydia
- Gonorrhea
Product type(s):
- MPTs
- VaginalCream
Topic(s):
- MPTs
- Development
- Trials
URL of resource: